ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.96%
US Tech 100
18,064.80
0.02%
S&P 500
5,277.51
0.80%
US Dollar vs CAD
1.36525
-0.01%
Bitcoin
67,626.96
0.22%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Endo International PLC (ENDP)

  7. Endo International PLC (ENDP) News

ENDP

Endo (ENDP)

Endo International PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ENDP
DateTimeSourceHeadlineSymbolCompany
09/21/20236:45AMPR Newswire (Canada)Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual MeetingNASDAQ:ENDPEndo International PLC
09/21/20236:45AMPR Newswire (US)Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual MeetingNASDAQ:ENDPEndo International PLC
08/08/20236:45AMPR Newswire (US)ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTSNASDAQ:ENDPEndo International PLC
08/08/20236:45AMPR Newswire (Canada)ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTSNASDAQ:ENDPEndo International PLC
07/18/20233:30PMPR Newswire (US)Endo Launches Bivalirudin Injection in Ready-to-Use VialsNASDAQ:ENDPEndo International PLC
07/13/20233:30PMPR Newswire (US)Endo Presents New Data at the American Podiatric Medical Association Annual MeetingNASDAQ:ENDPEndo International PLC
06/29/20233:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ENDPEndo International PLC
06/12/20236:30AMPR Newswire (US)Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled SyringeNASDAQ:ENDPEndo International PLC
06/12/20236:30AMPR Newswire (US)Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled SyringeNASDAQ:ENDPEndo International PLC
06/12/20236:30AMPR Newswire (Canada)Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled SyringeNASDAQ:ENDPEndo International PLC
05/08/20236:37AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ENDPEndo International PLC
05/08/20236:30AMPR Newswire (US)ENDO REPORTS FIRST-QUARTER 2023 FINANCIAL RESULTSNASDAQ:ENDPEndo International PLC
04/17/20236:45AMPR Newswire (US)Endo Announces Launch of Argatroban Injection Through Premier's ProRx® Private-Label ProgramNASDAQ:ENDPEndo International PLC
04/03/20233:30PMPR Newswire (Canada)Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral SuspensionNASDAQ:ENDPEndo International PLC
04/03/20233:30PMPR Newswire (US)Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral SuspensionNASDAQ:ENDPEndo International PLC
03/13/20233:17PMPR Newswire (US)Endo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolyticum (CCH) in Participants With Plantar FibromatosisNASDAQ:ENDPEndo International PLC
03/10/20236:30AMPR Newswire (US)Endo Launches First Generic Version of Pylera® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) CapsulesNASDAQ:ENDPEndo International PLC
03/06/20233:14PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:ENDPEndo International PLC
03/06/20238:32AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ENDPEndo International PLC
03/06/20238:28AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ENDPEndo International PLC
02/27/20234:15PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ENDPEndo International PLC
02/27/20234:10PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ENDPEndo International PLC
02/27/20234:05PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ENDPEndo International PLC
02/27/20234:00PMEdgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:ENDPEndo International PLC
02/14/20238:00AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ENDPEndo International PLC
02/13/202311:39AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ENDPEndo International PLC
02/06/20236:30AMPR Newswire (US)Endo Launches "Man With a Plan" Campaign to Support Men With Symptoms of Peyronie's DiseaseNASDAQ:ENDPEndo International PLC
01/31/20234:06PMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ENDPEndo International PLC
12/22/20223:24PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ENDPEndo International PLC
12/06/20223:45PMPR Newswire (US)Endo to Cease Production and Sale of Qwo® (collagenase clostridium histolyticum-aaes)NASDAQ:ENDPEndo International PLC
 Showing the most relevant articles for your search:NASDAQ:ENDP

Your Recent History

EU
SGGB
Societe Generale SA 3.29...
BIT
UB8PF9
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved